Tykerb 250 mg Tablet
Request Pricing & Availability
Fill in your details below and our clinical team will get back to you with pricing & availability within 24 hours.
Similar Products
| Product | Manufacturer / Marketed By | Price |
|---|---|---|
Hertab 250 mg Tablet
|
Hetero Healthcare | Ask for Price |
|
Combinib 250 mg Tablet
|
Cipla | Ask for Price |
Herduo 250 mg Tablet
|
Natco Pharma | Ask for Price |
Description
Tykerb 250 mg Tablets are manufactured by NOVARTIS INDIA LTD in United Kingdom and contain 250 mg of Lapatinib per tablet. Each Bottle includes 30 tablets per bottle, making Tykerb 250 mg Tablets an effective option for Breast Cancer . Prescription Required from your healthcare provider to purchase Lapatinib medicine. Indogenmed deals in all type of generic Lapatinib medicine.
Related Products
-
Lenvitib 10 mg Capsule
LenvatinibPrice on request
Request pricing -
Lucimird 1 mg Capsule
Price on request
Request pricing -
Luciorfor 17.2 mg Tablet
Price on request
Request pricing -
Luciorfor 14.5 mg Tablet
Price on request
Request pricing -
Luciorfor 9 mg Tablet
Price on request
Request pricing -
Luciorfor 5.5 mg Tablet
Price on request
Request pricing -
Luciorfor 2.5 mg Tablet
Price on request
Request pricing -
Luciorfor 0.8 mg Tablet
Price on request
Request pricing -
LuciPemafib 0.1 mg Tablet
Price on request
Request pricing -
LuciVeric 10 mg Tablet
Price on request
Request pricing -
LuciLemb 5 mg Tablet
Price on request
Request pricing -
LuciElag 200 mg Tablet
Price on request
Request pricing
Related Reading
-
FDA Approves Vepdegestrant for ER+/HER2–, ESR1-Mutated Breast Cancer: A New Targeted Option
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 6, 2026. Breast cancer treatment continues to evolve
-
First-Line Palbociclib Combination Boosts PFS in HR+/HER2+ mBC – PATINA Findings
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 1, 2026. n Metastatic breast cancer (mBC) remains
-
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue
-
Healing After Radiation: Is a Nipple-Sparing Mastectomy Possible?
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 20, 2026. n For many years, patients who
-
Oral SERDs Explained: The New Hormone Therapy Option After Endocrine Resistance in HR+ Breast Cancer
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 25, 2026. n Hormone receptor-positive, HER2-negative breast cancer
-
Does Ribociclib Still Help After 3 Years? The NATALEE Trial’s 4-Year Follow-Up Answers
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 21, 2026. n For patients with hormone receptor–positive,
Shipping & Delivery
- Ships from
- India, worldwide delivery
- Order processing
- 1–3 business days after checks
- Transit time
- 5–7 business days by express courier
- Tracking
- Tracking number sent by email or SMS
- Packaging
- Discreet, tamper-evident, cold-chain available
- Duties & taxes
- Payable by the recipient on import